4Crown S,Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients, the Middlesex Hospital Questionnaire (M.H.Q.) [J]. Br J Psychiatry, 1966,112(490) : 917-23.
5Haaland B, Chopra A, Acharyya S, et al. Comparative ef- fectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma [J]. BMC Cancer, 2014,14( 1 ) :592.
6Ricotta R, Di Bella S. Outcomes of patients with metastat- ic renal cell carcinoma treated with pazopanib in daily clinical practice :a single institution experience [J]. Tu- mori ,2014,100(3 ) :e87-e91.
7Von Schulz-Hausmann SA,Schmeel LC,Schmeel FC,et al.Targeting the wnt/beta-catenin pathway in renal cell car- cinoma [J]. Anticancer Res,201d,34(8) :4101-4108.
